Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of

L W Whitney1, S K Ludwin, H F McFarland

  • 1Molecular Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, NIH, Bldg. 10/Rm 5B-16, Bethesda, MD 20892-1400, USA.

Insights

Researchers identified 5-lipoxygenase (5-LO), an enzyme involved in inflammation, as upregulated in multiple sclerosis (MS) lesions. This finding suggests 5-LO may be a therapeutic target for MS treatment.

Area of Science:

  • Neuroscience
  • Immunology
  • Genetics

Background:

  • Multiple sclerosis (MS) is a central nervous system demyelinating disease.
  • MS lesions involve blood-brain barrier breakdown, inflammation, and myelin damage.

Purpose of the Study:

  • To identify genes contributing to MS lesion pathology.
  • To compare gene expression in MS lesions and EAE mouse models with normal white matter.

Main Methods:

  • Gene expression analysis using cDNA microarrays (2798 human genes).
  • Immunohistochemistry to confirm protein presence in lesions.

Main Results:

  • 5-lipoxygenase (5-LO), a key enzyme in pro-inflammatory leukotriene biosynthesis, was upregulated in both MS lesions and EAE mouse brains.
  • Immunohistochemistry confirmed 5-LO presence primarily within macrophages in MS lesions.

Conclusions:

  • Upregulated 5-LO is a potentially significant factor in MS inflammatory activity and demyelination.
  • 5-LO presents a possible therapeutic target for anti-inflammatory strategies in MS.

Related Concept Videos